APR 08, 2017 10:38 AM PDT

FDA Approves 10 At-Home Genetic Tests


Any person curious about their personal genetic predisposition to 10 relatively well-known diseases can now do it in the comfort of their own home, sans physician referrals. This is thanks to the FDA’s newest ruling, which will allow 23andme to sell these genetic risk tests straight to consumers.

“Consumers can now have direct access to certain genetic risk information,” said Jeffrey Shuren, the director of the FDA’s Center for Devices and Radiological Health. “But it is important that people understand that genetic risk is just one piece of the bigger puzzle, it does not mean they will or won’t ultimately develop a disease.”

This is an important distinction. The tests aren’t meant to dole out any diagnosis. Rather, these are intended to assess a person’s genetic risks of developing such disease, given their genetic profile. And to Dr. Shuren’s last point, high risks don’t necessarily mean the disease will definitely manifest, as lifestyle and other environmental factors also influence the outcome.

According to the FDA’s announcement, the 10 tests approved for direct-to-consumer (DTC) use include:

  • Parkinson’s disease: a nervous system disorder impacting movement;

  • Late-onset Alzheimer’s disease: a progressive brain disorder that destroys memory and thinking skills;

  • Celiac disease: a disorder resulting in the inability to digest gluten;

  • Alpha-1 antitrypsin deficiency: a disorder that raises the risk of lung and liver disease;

  • Early-onset primary dystonia: a movement disorder involving involuntary muscle contractions and other uncontrolled movements;

  • Factor XI deficiency: a blood clotting disorder;

  • Gaucher disease type 1: an organ and tissue disorder;

  • Glucose-6-Phosphate Dehydrogenase deficiency (G6PD): a red blood cell condition;

  • Hereditary hemochromatosis: an iron overload disorder; and

  • Hereditary thrombophilia: a blood clot disorder.

These 10 genetic health risk (GHR) test were approved based on extensive data “from peer-reviewed, scientific literature that demonstrated a link between specific genetic variants and each of the 10 health conditions,” per the FDA. The company 23andme also had to demonstrate that sufficient genetic information concerning these 10 GHR tests could be gleaned from just a saliva sample.

"This is an important moment for people who want to know their genetic health risks and be more proactive about their health," said Anne Wojcicki, the CEO and co-founder of 23andMe, in a press release.

But consumers should beware. Getting the GHR test results is only one part of the puzzle; accurately deciphering these results is arguable much trickier. According to the FDA release, results of these DTC tests should “be communicated in a way that consumers can understand and use.” Even so, because the origins of these diseases are complex, involving the interplay between genes and environmental factors, it probably would be wise to seek help from trained genetic counselors in interpreting these results.

Of note, curious consumers would also do well to consider that some diseases on this list, such as Parkinson’s and Alzheimer’s disease, don’t yet have cures. While this information may benefit people who have a family history, it may also bring undue stress for others and their families. So while knowledge is power, taking genetic tests should not be taken lightly.

Additional Source: NPR, CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 20, 2018
Chemistry & Physics
JUL 20, 2018
X-ray Images to Get Colors
In the near future, the X-ray images from your doctor's office will no longer be just black and white, at least that's what MARS Bioimaging Ltd, an...
AUG 22, 2018
Clinical & Molecular DX
AUG 22, 2018
New Clinical Assay Useful For Urothelial Cancer
U.S. Food and Drug Administration (FDA) has now approved a pharmDx assay called ‘Dako PD-L1 IHC 22C3’ by Agilent Technologies Inc. for use in u...
SEP 03, 2018
Clinical & Molecular DX
SEP 03, 2018
Patients fewer symptoms after these words from doctors
A few encouraging words about recovery time from a health care provider after an allergic reaction significantly reduces symptoms, according to a new study...
NOV 26, 2018
Health & Medicine
NOV 26, 2018
A New Test for Fibromyalgia
Anyone who has experienced severe, chronic pain knows the long process it takes to get a correct diagnosis. Many people see an average of 5-6 specialists b...
NOV 29, 2018
NOV 29, 2018
Screening IVF Embryos for Low IQ
A new test purports to be able to identify embryos with a high chance of having a low IQ....
DEC 04, 2018
DEC 04, 2018
Natural HIV Resistance
A team of scientists discover unique immune reactions to the one percent of HIV infected patients that are able to fend off viral propagation without antiretroviral therapy...
Loading Comments...